Home  »  Finance   »  New Big Money Means Twist Bioscience Corporation (...

New Big Money Means Twist Bioscience Corporation (TWST) Investors Could Reap Benefit

Twist Bioscience Corporation (NASDAQ: TWST) is -40.19% lower on its value in year-to-date trading and has touched a low of $11.46 and a high of $58.76 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TWST stock was last observed hovering at around $14.92 in the last trading session, with the day’s loss setting it -0.68% off its average median price target of $19.00 for the next 12 months. It is also 56.85% off the consensus price target high of $33.00 offered by 9 analysts, but current levels are -29.45% lower than the price target low of $11.00 for the same period.

Currently trading at $14.24, the stock is 9.75% and 1.13% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.27 million and changing -4.56% at the moment leaves the stock -46.41% off its SMA200. TWST registered -61.95% loss for a year compared to 6-month loss of -44.40%. The firm has a 50-day simple moving average (SMA 50) of $1.70 and a 200-day simple moving average (SMA200) of -$1.83.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


The stock witnessed a 11.42% gain in the last 1 month and extending the period to 3 months gives it a -29.19%, and is 9.71% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.64% over the week and 7.92% over the month.

Twist Bioscience Corporation (TWST) has around 989 employees, a market worth around $818.80M and $227.80M in sales. Profit margin for the company is -93.30%. Distance from 52-week low is 24.26% and -75.77% from its 52-week high. The company has generated returns on investments over the last 12 months (-27.80%).

Twist Bioscience Corporation (TWST) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Twist Bioscience Corporation (TWST) is a “Overweight”. 9 analysts offering their recommendations for the stock have an average rating of 2.20, where 2 rate it as a Hold and 2 think it is a “Overweight”. 4 of the analysts rate the stock as a “Buy”. 1 analysts have rated the stock as a Sell or Underperform.

Twist Bioscience Corporation is expected to release its quarterly report on 08/04/2023.The EPS is expected to shrink by -28.30% this year

Twist Bioscience Corporation (TWST) Top Institutional Holders

The shares outstanding are 56.78M, and float is at 56.00M with Short Float at 22.09%.

Twist Bioscience Corporation (TWST) Insider Activity

A total of 59 insider transactions have happened at Twist Bioscience Corporation (TWST) in the last six months, with sales accounting for 44 and purchases happening 15 times. The most recent transaction is an insider purchase by Cho Dennis, the company’s. SEC filings show that Cho Dennis bought 10,000 shares of the company’s common stock on May 10 at a price of $13.20 per share for a total of $0.13 million. Following the purchase, the insider now owns 29297.0 shares.

Twist Bioscience Corporation disclosed in a document filed with the SEC on Feb 09 that Starovasnik Melissa A. (Director) sold a total of 1,732 shares of the company’s common stock. The trade occurred on Feb 09 and was made at $26.45 per share for $45820.0. Following the transaction, the insider now directly holds 11340.0 shares of the TWST stock.

Still, SEC filings show that on Feb 09, JOHANNESSEN JAN (Director) disposed off 1,732 shares at an average price of $26.45 for $45820.0. The insider now directly holds 11,616 shares of Twist Bioscience Corporation (TWST).

Twist Bioscience Corporation (TWST): Who are the competitors?

The company’s main competitors (and peers) include Rogers Corporation (ROG) that is -41.31% lower over the past 12 months. Thermo Fisher Scientific Inc. (TMO) is -8.01% down on the 1-year trading charts.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts